Premier, Inc. (PINC)

$20.79

+0.15

(+0.73%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Premier, Inc.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 318.75M → 334.74M (in $), with an average increase of 4.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 21.46M → 54.30M (in $), with an average increase of 34.8% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 37.0% return, outperforming this stock by 72.6%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 12.5% return, outperforming this stock by 53.8%

Performance

  • $20.66
    $20.95
    $20.79
    downward going graph

    0.63%

    Downside

    Day's Volatility :1.36%

    Upside

    0.74%

    downward going graph
  • $18.32
    $31.43
    $20.79
    downward going graph

    11.88%

    Downside

    52 Weeks Volatility :41.71%

    Upside

    33.85%

    downward going graph

Returns

PeriodPremier, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-6.56%
-0.7%
0.0%
6 Months
2.43%
6.6%
0.0%
1 Year
-35.6%
3.7%
-1.5%
3 Years
-41.71%
14.0%
-21.8%

Highlights

Market Capitalization
2.5B
Book Value
$19.95
Dividend Share
0.84
Dividend Yield
4.06%
Earnings Per Share (EPS)
1.39
PE Ratio
15.12
PEG Ratio
1.6
Wall Street Target Price
24.39
Profit Margin
12.71%
Operating Margin TTM
20.37%
Return On Assets TTM
6.11%
Return On Equity TTM
6.93%
Revenue TTM
1.3B
Revenue Per Share TTM
11.04
Quarterly Revenue Growth YOY
-6.9%
Gross Profit TTM
896.3M
EBITDA
491.8M
Diluted Eps TTM
1.39
Quarterly Earnings Growth YOY
-0.16
EPS Estimate Current Year
2.15
EPS Estimate Next Year
2.36
EPS Estimate Current Quarter
0.57
EPS Estimate Next Quarter
0.52

Analyst Recommendation

Buy
    50%Buy
    42%Hold
    7%Sell
Based on 14 Wall street analysts offering stock ratings for Premier, Inc.(by analysts ranked 0 to 5 stars)
Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
9
Hold
6
6
7
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 17.32%

Current $20.79
Target $24.39

Company Financials

FY18Y/Y Change
Revenue
1.7B
↑ 14.2%
Net Income
33.3M
↓ 70.64%
Net Profit Margin
2.0%
↓ 5.8%
FY19Y/Y Change
Revenue
1.2B
↓ 26.7%
Net Income
334.7M
↑ 905.01%
Net Profit Margin
27.49%
↑ 25.49%
FY20Y/Y Change
Revenue
1.3B
↑ 6.73%
Net Income
291.1M
↓ 13.01%
Net Profit Margin
22.4%
↓ 5.09%
FY21Y/Y Change
Revenue
1.7B
↑ 32.44%
Net Income
287.5M
↓ 1.24%
Net Profit Margin
16.71%
↓ 5.69%
FY22Y/Y Change
Revenue
1.4B
↓ 16.75%
Net Income
265.9M
↓ 7.53%
Net Profit Margin
18.55%
↑ 1.84%
FY23Y/Y Change
Revenue
1.3B
↓ 6.76%
Net Income
175.0M
↓ 34.17%
Net Profit Margin
13.1%
↓ 5.45%
Q3 FY22Q/Q Change
Revenue
313.9M
↓ 7.88%
Net Income
42.7M
↑ 42.85%
Net Profit Margin
13.61%
↑ 4.83%
Q4 FY22Q/Q Change
Revenue
359.6M
↑ 14.58%
Net Income
64.0M
↑ 49.93%
Net Profit Margin
17.81%
↑ 4.2%
Q1 FY23Q/Q Change
Revenue
322.2M
↓ 10.4%
Net Income
46.8M
↓ 26.93%
Net Profit Margin
14.52%
↓ 3.29%
Q2 FY23Q/Q Change
Revenue
340.4M
↑ 5.63%
Net Income
21.5M
↓ 54.14%
Net Profit Margin
6.31%
↓ 8.21%
Q3 FY23Q/Q Change
Revenue
318.8M
↓ 6.35%
Net Income
44.8M
↑ 108.55%
Net Profit Margin
14.04%
↑ 7.73%
Q4 FY23Q/Q Change
Revenue
334.7M
↑ 5.02%
Net Income
54.3M
↑ 21.32%
Net Profit Margin
16.22%
↑ 2.18%
FY18Y/Y Change
Total Assets
2.3B
↓ 7.8%
Total Liabilities
3.7B
↓ 10.33%
FY19Y/Y Change
Total Assets
2.6B
↑ 11.13%
Total Liabilities
3.4B
↓ 8.22%
FY20Y/Y Change
Total Assets
2.9B
↑ 14.75%
Total Liabilities
2.8B
↓ 18.14%
FY21Y/Y Change
Total Assets
3.5B
↑ 19.48%
Total Liabilities
1.3B
↓ 53.97%
FY22Y/Y Change
Total Assets
3.4B
↓ 4.71%
Total Liabilities
1.1B
↓ 14.29%
FY23Y/Y Change
Total Assets
3.4B
↑ 0.43%
Total Liabilities
1.0B
↓ 6.42%
Q3 FY22Q/Q Change
Total Assets
3.4B
↑ 1.87%
Total Liabilities
1.2B
↑ 4.52%
Q4 FY22Q/Q Change
Total Assets
3.5B
↑ 3.5%
Total Liabilities
1.2B
↑ 6.47%
Q1 FY23Q/Q Change
Total Assets
3.5B
↓ 0.76%
Total Liabilities
1.2B
↓ 4.59%
Q2 FY23Q/Q Change
Total Assets
3.4B
↓ 4.02%
Total Liabilities
1.0B
↓ 11.86%
Q3 FY23Q/Q Change
Total Assets
3.8B
↑ 14.18%
Total Liabilities
1.5B
↑ 44.33%
Q4 FY23Q/Q Change
Total Assets
3.8B
↓ 0.44%
Total Liabilities
1.4B
↓ 3.64%
FY18Y/Y Change
Operating Cash Flow
507.7M
↑ 29.44%
Investing Cash Flow
-92.7M
↓ 80.07%
Financing Cash Flow
-419.4M
↑ 2075.63%
FY19Y/Y Change
Operating Cash Flow
505.3M
↓ 0.47%
Investing Cash Flow
-129.5M
↑ 39.7%
Financing Cash Flow
-387.2M
↓ 7.67%
FY20Y/Y Change
Operating Cash Flow
349.5M
↓ 30.83%
Investing Cash Flow
-222.3M
↑ 71.72%
Financing Cash Flow
-169.0M
↓ 56.37%
FY21Y/Y Change
Operating Cash Flow
407.4M
↑ 16.56%
Investing Cash Flow
-174.6M
↓ 21.48%
Financing Cash Flow
-203.0M
↑ 20.15%
FY22Y/Y Change
Operating Cash Flow
444.2M
↑ 9.04%
Investing Cash Flow
-139.4M
↓ 20.12%
Financing Cash Flow
-347.8M
↑ 71.33%
FY23Y/Y Change
Operating Cash Flow
444.5M
↑ 0.07%
Investing Cash Flow
-273.6M
↑ 96.23%
Financing Cash Flow
-167.3M
↓ 51.91%
Q3 FY22Q/Q Change
Operating Cash Flow
74.8M
↓ 31.7%
Investing Cash Flow
-20.2M
↓ 23.31%
Financing Cash Flow
36.0M
↓ 120.39%
Q4 FY22Q/Q Change
Operating Cash Flow
122.0M
↑ 63.17%
Investing Cash Flow
-207.2M
↑ 924.4%
Financing Cash Flow
3.3M
↓ 90.96%
Q1 FY23Q/Q Change
Operating Cash Flow
134.5M
↑ 10.23%
Investing Cash Flow
-22.3M
↓ 89.23%
Financing Cash Flow
-115.3M
↓ 3642.29%
Q2 FY23Q/Q Change
Operating Cash Flow
113.4M
↓ 15.68%
Investing Cash Flow
-23.8M
↑ 6.81%
Financing Cash Flow
-91.2M
↓ 20.85%

Technicals Summary

Sell

Neutral

Buy

Premier, Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Premier, Inc.
Premier, Inc.
-5.28%
2.43%
-35.6%
-41.71%
-35.44%
Solventum Corp
Solventum Corp
-10.64%
-10.64%
-10.64%
-10.64%
-10.64%
Veeva Systems Inc.
Veeva Systems Inc.
-12.8%
-3.39%
8.83%
-26.33%
55.83%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-5.98%
30.6%
1.83%
40.83%
40.83%
Healthequity Inc
Healthequity Inc
-3.72%
6.22%
37.05%
12.91%
23.47%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Premier, Inc.
Premier, Inc.
15.12
15.12
1.6
2.15
0.07
0.06
0.04
19.95
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
62.03
62.03
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
28.08
28.08
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
125.42
125.42
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Premier, Inc.
Premier, Inc.
Buy
$2.5B
-35.44%
15.12
12.71%
Solventum Corp
Solventum Corp
NA
$11.7B
-10.64%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.3B
55.83%
62.03
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.0B
40.83%
28.08
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
23.47%
125.42
5.57%

Institutional Holdings

  • BlackRock Inc

    13.59%

  • Vanguard Group Inc

    11.86%

  • Pacer Advisors, INC.

    4.68%

  • Goldman Sachs Group Inc

    3.54%

  • State Street Corporation

    3.53%

  • Dimensional Fund Advisors, Inc.

    3.44%

Corporate Announcements

  • Premier, Inc. Dividends March,2024

    In the quarter ending March,2024. Premier, Inc. has declared dividend of $0.21

    Read More

Company Information

as a leading national healthcare solutions organization, premier, inc. collaborates with healthcare organizations to improve supply chain management, decrease healthcare costs, integrate data and improve the health of communities. as an industry leader, premier has created one of the most comprehensive database of actionable data, best practices and cost reduction strategies. we enable our members to collaborate easily and efficiently improve their quality outcomes, while reducing costs. by engaging members and revealing new opportunities, we empower our alliance to improve performance like no one else in healthcare can.

Organization
Premier, Inc.
Employees
2800
CEO
Mr. Michael J. Alkire
Industry
Health Services

Discover More

FAQs